A clinical study to compare the the sedative drug combination dexmedetomidine plus ketamine and midazolam plus ketamine on patients undergoing short surgical procedures.
- Conditions
- Abnormal uterine and vaginal bleeding, unspecified, (2) ICD-10 Condition: K929||Disease of digestive system, unspecified, (3) ICD-10 Condition: N359||Urethral stricture, unspecified,
- Registration Number
- CTRI/2021/08/035523
- Lead Sponsor
- Dr Seethal Ann Sunny
- Brief Summary
This study is a prospective, double blinded randomised controlled study comparing the effect of intravenous ketamine hydrochloride plus dexmedetomidine hydrochloride and intravenous ketamine hydrochloride plus midazolam hydrochloride in procedural sedation for short surgical procedures. different drug combinations have been used for sedation in short surgical procedures. Here we tried to compare two drug combinations and try to find out a superior combination which would provide adequate sedation, hemodynamic stability and less postoperative complications.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 100
Consent to participate in study ASA physical Grade 1 and 2 Patients undergoing short surgical procedures.
- Patients refusal.
- Pregnancy and lactating women.
- History of any significant pulmonary, cardiovascular, neurological, hepatoreanal or metabolic disease.
- chronic use or addiction to opiates or sedatives.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method we expect that dexmedetomidine plus ketamine will provide adequate depth of anaesthesia and more stable hemodynamic variables. 20 weeks
- Secondary Outcome Measures
Name Time Method We expect dexmedetomidine plus ketamine to provide less incidence of postoperative complications 20 weeks
Trial Locations
- Locations (1)
GR Medical College Gwalior
🇮🇳Gwalior, MADHYA PRADESH, India
GR Medical College Gwalior🇮🇳Gwalior, MADHYA PRADESH, IndiaDr Seethal Ann SunnyPrincipal investigator9495280289seethalannsunny92@gmail.com